The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions And Methods For Treating Anemia - EP3007695

The patent EP3007695 was granted to Akebia Therapeutics on Feb 7, 2024. The application was originally filed on Jun 4, 2014 under application number EP14811317A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3007695

AKEBIA THERAPEUTICS
Application Number
EP14811317A
Filing Date
Jun 4, 2014
Status
Granted And Under Opposition
Jan 5, 2024
Publication Date
Feb 7, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZNov 6, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007299086
EXAMINATIONWO03053997
INTERNATIONAL-SEARCH-REPORTUS2007299086
INTERNATIONAL-SEARCH-REPORTUS2012309977
INTERNATIONAL-SEARCH-REPORTUS2014057892
OPPOSITIONUS2007299086
OPPOSITIONWO2014200773
SEARCHUS2007299086

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents